![](/img/cover-not-exists.png)
PCN31 COST MINIMIZATION ANALYSIS OF CAPECITABINE+CISPLATIN IV VS 5-FLUORURACIL IV+CISPLATIN IVAS FIRST LINE THERAPY FORADVANCED GASTRIC CANCER FROM THE BRAZILIAN SOCIETAL PERSPECTIVE
A Malzyner, MG Saggia, V NascibenVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65189-3
File:
PDF, 74 KB
english, 2007